
Your Partner in APAC Life Science and R&D Asset Management
Vita Partners focuses on generating long-term value for our real estate investment partners through active asset and investment portfolio management across Asia Pacific.
With deep expertise in innovation, life sciences, and R&D real estate, Vita Partners delivers asset enhancement, development, and repositioning strategies designed to optimise returns across market cycles.
Today, the platform actively manages assets through enhancement, development and recycling to optimise returns on high-performing investment portfolios across Singapore and other APAC markets.
>S$2B
outperforming assets under management
5M sq ft
of gross
floor area
>150 tenants
across
managed assets
>30 years
of experience with life sciences, innovation and R&D clients

The Life Science and R&D Investment Thesis
With the world’s largest population, highest proportion of ageing individuals globally, national strategies to build research capability, increased innoivation and reduced reliance on external supply chains, there are long-term structural demands in APAC that continue to drive life sciences and R&D real estate. All of these reinforce long-term demand for specialised laboratory, production, and R&D facilities.

LINO Fund
Created in 2022, LINO is a S$1B partnership investing in innovation and life sciences focused real estate assets with a focus on Australia, Japan and Singapore.